Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01851239
Recruitment Status : Completed
First Posted : May 10, 2013
Last Update Posted : May 5, 2014
Information provided by (Responsible Party):
Yonsei University

Brief Summary:

Venous thromboembolism(VTE) is the third most common cardiovascular complication among hospitalized patients, and can even cause death. VTE often occurs in intensive care patients and there had been many efforts to prevent such complication. The American College of Chest Physicians (ACCP) had published evidence-based clinical practice guideline for VTE prophylaxis.

This study focuses on how VTE prophylaxis is being performed in both medical and surgical ICUs in a single University hospital, and sees the differences in such prophylactic patterns.

Condition or disease
Venous Thromboembolism

Study Type : Observational
Actual Enrollment : 1000 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Study Start Date : February 2013
Actual Primary Completion Date : July 2013
Actual Study Completion Date : April 2014

medical ICU inpatients
surgical ICU inpatients

Primary Outcome Measures :
  1. number of patients prescribed with any measures of VTE prophylaxis in ICU [ Time Frame: at the time of ICU admission an expected average of 5 months (When VTE prophylaxis for each patient is being ordered) ]
    The object of this study is to see the percentage of ICU admitted patients prescribed with VTE prophylaxis, and analyze the adequacy of such prophylactic measure according to the international guideline. Moreover, difference between the VTE prophylaxis pattern of medical and surgical ICUs will also be seek for further analysis.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
ICU admitted patients who are indicated for VTE prophylaxis.

Inclusion Criteria:

  • ICU admitted patients

Exclusion Criteria:

  • patients under 20 years old

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01851239

Korea, Republic of
Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine
Seoul, Korea, Republic of, 120-752
Sponsors and Collaborators
Yonsei University

Responsible Party: Yonsei University Identifier: NCT01851239     History of Changes
Other Study ID Numbers: 1-2013-0002
First Posted: May 10, 2013    Key Record Dates
Last Update Posted: May 5, 2014
Last Verified: May 2014

Keywords provided by Yonsei University:
Venous Thromboembolism Prophylaxis

Additional relevant MeSH terms:
Venous Thromboembolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases